The Oncology Institute (TOI) Cash Flow: Operating & Free Cash Flow

The Oncology Institute Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for The Oncology Institute, Inc. (TOI) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Operating Activities
Net Income	-60.61	-53.01	-83.07	0.15	-10.93	-14.32	-4.02
Depreciation & Amortization	6.94	6.29	5.87	4.41	3.34	3.18	2.94
Deferred Income Tax	-0.03	0.00	-0.08	-0.26	-1.24	-1.34	0.82
Stock Based Compensation	4.55	11.15	17.81	27.68	24.54	0.15	0.09
Change in Working Capital	1.33	18.06	2.36	-20.54	-14.49	0.99	3.45
Change in Accounts Receivable	-12.58	-5.77	-4.50	-19.67	-2.99	-6.76	-4.44
Change in Inventory	-6.84	3.64	-4.39	-1.73	-1.84	-0.47	-1.13
Change in Accounts Payable	19.64	9.22	5.06	-6.06	2.92	3.76	5.53
Change in Other Working Capital	1.11	10.98	6.19	-56.77	-8.48	3.81	3.49
Other Operating Activities	23.23	2.12	20.79	-56.77	-35.14	-1.34	0.33
Net Cash from Operating Activities	-24.59	-26.54	-36.32	-61.76	-32.68	0.51	3.62
Investing Activities
Capital Expenditures	-3.20	-3.79	-4.57	-5.53	-2.85	-1.19	-1.20
Acquisitions	0.00	0.00	-4.46	-8.58	-9.11	-0.15	0.00
Purchases of Investments	0.00	0.00	-9.60	-117.51	0.00	0.00	0.00
Sales/Maturities of Investments	0.13	50.00	81.26	0.00	-0.20	0.00	0.00
Other Investing Activities	0.00	0.00	0.00	0.00	-0.20	-7.50	0.00
Net Cash from Investing Activities	-3.07	46.21	62.64	-131.61	-12.15	-8.84	-1.20
Financing Activities
Debt Repayment	-20.04	-0.04	-0.10	-0.06	-7.22	12.18	0.00
Common Stock Issued	32.63	0.08	0.00	0.00	333.95	0.05	0.00
Common Stock Repurchased	0.00	0.00	-1.02	-9.00	0.00	0.00	0.00
Other Financing Activities	-1.04	-3.53	-5.73	-9.59	-192.72	-0.34	0.00
Net Cash from Financing Activities	11.56	-3.49	-6.85	92.21	154.01	11.89	0.00
Summary
Net Change in Cash	-16.10	16.18	19.48	-101.16	109.18	3.55	2.41
Cash at Beginning of Period	49.67	33.49	14.01	115.17	6.00	2.45	0.04
Cash at End of Period	33.57	49.67	33.49	14.01	115.17	6.00	2.45
Free Cash Flow	-27.79	-30.33	-40.88	-67.29	-35.53	-0.69	2.41
Supplemental Disclosures
Interest Paid	-	4.50	4.51	0.22	0.28	0.23	-
Income Taxes Paid	-	-	0.40	0.15	1.73	0.21	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About The Oncology Institute Cash Flow

What is The Oncology Institute's free cash flow?

The Oncology Institute had negative free cash flow of $27.79M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$24.59M minus $3.20M of capital expenditures.

How much does The Oncology Institute spend on capital expenditures?

The Oncology Institute spent $3.20M on capital expenditures in fiscal 2025, compared with $3.79M a year earlier.

Does The Oncology Institute pay dividends or buy back shares?

The Oncology Institute's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition